Low levels of plasma soluble complement receptor type 1 in patients receiving thrombolytic therapy for acute myocardial infarction

By Karthikeyan Ganesan   Baalasubramanian Sivasankar   Seth Sandeep   Das Nibhriti  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 2, 2007-04 ,pp. : 115-120

Springer Publishing Company

Access to resources Recommend Favorite

Improvement in Long-term Prognosis of Elderly Patients with Acute Myocardial Infarction After the Introduction of Intravenous Thrombolytic Therapy

By Madsen Johnny Koerstz   Pedersen Flemming   Nielsen Henrik   Jensen Gunnar Vagn   Hansen Jørgen Fischer  

Scandinavian Cardiovascular Journal, Vol. 32, Iss. 6, 1998-11 ,pp. : 365-370

Informa Healthcare

Access to resources Recommend Favorite

The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction

By Menyar Ayman   Altamimi O.   Gomaa Mohamed   Fawzy Zainab   Rahman M.   Bener Abdulbari  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 3, 2006-06 ,pp. : 235-240

Springer Publishing Company

Access to resources Recommend Favorite

Thrombolytic Therapy Preserves Vagal Activity Early after Acute Myocardial Infarction

By Lind Pernille   Hintze Ulrik   Møller Mogens   Mickley Hans  

Scandinavian Cardiovascular Journal, Vol. 35, Iss. 2, 2001-03 ,pp. : 92-95

Informa Healthcare

Access to resources Recommend Favorite

In-hospital Outcome for Diabetic Patients with Acute Myocardial Infarction in the Thrombolytic Era

By Kjærgaard Søren Christensen   Hansen Hans-Henrik Tilsted   Fog Lars   Bülow Inge   Christensen Per Dahl  

Scandinavian Cardiovascular Journal, Vol. 33, Iss. 3, 1999-08 ,pp. : 166-170

Informa Healthcare

Access to resources Recommend Favorite